SCHEME 2. Possible Reaction Pathways for
Gold-Catalyzed Rearrangement of Propargylic Acetates
FIGURE 1. Colchicine and allocolchicinoids.
exclusively, leading to the cycloheptyl derivative 5. For n ) 2
and 3, the strain incurred in forming eight- and nine-membered
rings presumably makes path a more difficult, allowing the
formation of allenyl acetates 7 and 9.10
We decided next to use the tricyclic structure 5 containig a
seven-membered ring for the synthesis of a new class of
allocolchicinoids. Allocolchicinoids are analogues of the im-
portant antimitotic (-)-colchicine 12, in which the tropolone
ring is replaced by a benzene ring (Figure 1). Like colchicine,
some allocolchicinoids also arrest mitosis by inhibiting tubulin
polymerization.11,12 Examples include natural allocolchicine 13,
N-acetylcolchinol 14, and its methyl ether which bind to tubulin
more strongly than colchicine itself. Total syntheses of 13 and
14 have been reported, and a number of syntheses of various
allocolchicinoids have also been described.13
Recently, we described the synthesis of allocolchicine 15,
analogue of 13, having the ester group at position C10.14,15 This
compound was found to be as active as natural allocolchicine
13.16 We report now the synthesis of a new allocolchicinoid
16, in which the acetamide function in 15 has been replaced by
a cyclopropane ring fused to the seven-membered ring at the
C6-C7 positions.
The retrosynthetic analysis is outlined in Scheme 3. Thus,
the target compound 16 could be prepared by a Diels-Alder/
aromatization sequence from diene 17. This intermediate can
be traced back to 18, which is formed by the Au(I) cycloi-
somerization reaction of enyne 2. This precursor was prepared
from aldehyde 19.15
As shown in Scheme 4, alkynylation of aldehyde 19 followed
by treatment of the resulting hydroxy ester with a catalytic
amount of TsOH in CH2Cl2 afforded lactone 20 in 61% overall
bearing the bis(trifluoromethanesulfonyl)imidate moiety.7 When
1 was treated with the biphenylphosphine-based catalyst 10 (1%)
in CH2Cl2 at room temperature, 4 was obtained in an improved
yield (78%) (Table 1, entry 2). Under these conditions, allene
7 was also isolated in 8% yield. In this skeletal reorganization,
enyne 1 was converted into a complex structure in which the
cyclopropane ring is fused to the eight-membered ring.5 The
use of the bulkier Au(I) catalyst 11 was found to be synthetically
less useful. Thus, treatment of enyne 1 with 11 gave allene
acetate 7 (16%), enol acetate 4 (60%), and a mixture of
unidentified products (Table 1, entry 3).
We next turned to the preparation of the tricyclic structure 5
containing a seven-membered ring. When propargylic acetate
2 was treated with 0.5% of catalyst 10, only the product of
cycloisomerization 5 was obtained in 90% yield (Table 1, entry
4). In this case, none of allene derivative 8 was isolated. By
sharp contrast, 1,9-enyne 3 (n ) 3)6 reacted rather sluggishly
under the same conditions (entry 5). In fact, to achieve the total
conversion of the starting enyne, further amounts of catalyst
10 (4%) were needed. Ultimately, the reaction gave a mixture
of products from which allenyl acetate 9 was isolated as the
major product in low yield (32%). Only 5% of cyclononane
derivative 6 was obtained.
To account for the formation of both enol esters and allenyl
acetates, a proposed mechanism is shown in Scheme 2. The
acetate group in the polarized metal-alkyne complex initially
formed can undergo either 1,2-O-acyl shift (path a)8 or 1,3-
acyl shift (path b) leading to a M-carbene A or to an allene B,
respectively. These complexes are poised for subsequent func-
tionalization: cyclopropanation of A leads to the tricyclic
derivative C, while B affords allene acetate D.9 The D/C ratio
strongly depends upon the cyclization efficiency, which is related
to ring size. For n ) 1, ring closure of intermediate A occurred
(10) Presumably, for the same reasons, 1,4-enynes (Scheme 1, n ) 0) do
not lead to the highly strained [2.1.0]bicyclic system. Instead, 2-cyclopentenones
are formed through the Rautenstrauch rearrangement. See: (a) Rautenstrauch,
V. J. Org. Chem. 1984, 49, 950. (b) Shi, X.; Gorin, D. J.; Toste, F. D. J. Am.
Chem. Soc. 2005, 127, 5802.
(11) For reviews on the synthesis and biological activity of colchicine and
allo congeners, see: (a) Graening, T.; Schmalz, H.-G. Angew. Chem., Int. Ed.
2004, 43, 3230. (b) Boye´, O.; Brossi, A. In The Alkaloids; Brossi, A., Cordell,
G. A., Eds.; Academic Press: New York, 1992; Vol. 41, p 125, and references
therein.
(12) For a review on microtubule-targeted drugs, see: Jordan, M. A.; Wilson,
L. Nat. ReV. Cancer 2004, 4, 253.
(13) For recent references, see: (a) Vorogushin, A. V.; Wulff, W. D.; Hansen,
H.-J. Tetrahedron 2008, 68, 949. (b) Besong, G.; Jarowski, K.; Kocienski, P. J.;
Sliwinski, E.; Boyle, F. T. Org. Biomol. Chem 2006, 4, 2193. (c) Leblanc, M.;
Fagnou, K. Org. Lett. 2005, 7, 2849. (d) Bu¨ttner, F.; Bergemann, S.; Gue´nard,
D.; Gust, R.; Seitz, G.; Thoret, S. Bioorg. Med. Chem. 2005, 13, 3497. (e) Wu,
T. R.; Chong, J. M. Org. Lett. 2006, 8, 15. (f) Vorogushin, A. V.; Predeus,
A. V.; Wulff, W. D.; Hansen, H.-J. J. Org. Chem. 2003, 64, 5826.
(14) The colchicine numbering has been used throughout this paper.
(15) Boyer, F.-D.; Hanna, I. Org. Lett. 2007, 9, 715.
(8) There is no general agreement on the respective order of 1,2-shift/
cyclopropanation. See for examples refs 2c and 4a and references cited therein.
(9) For examples of the formation of allenes as side products, see: Marion,
N.; Diez-Gonzalez, S.; de Fre´mont, P.; Noble, A. R.; Nolan, S. P. Angew. Chem.,
Int. Ed. 2006, 45, 3647. ref 2c.
(16) Boyer, F.-D.; Dubois, J.; Hanna, I. Unpublished work.
5164 J. Org. Chem. Vol. 73, No. 13, 2008